Electromed (ELMD) Share-based Compensation Growth (1y) (2011 - 2026)
Electromed (ELMD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.56% |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn | 107.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 260.20% |
| Dec 31, 2025 | 107.71% |
| Sep 30, 2025 | 93.28% |
| Jun 30, 2025 | -345.69% |
| Mar 31, 2025 | -258.80% |
| Dec 31, 2024 | -3,292.31% |
| Sep 30, 2024 | -2,410.34% |
| Jun 30, 2024 | -18,880.00% |
| Mar 31, 2024 | 2.43% |
| Dec 31, 2023 | -94.21% |
| Sep 30, 2023 | -51.67% |
| Jun 30, 2023 | 100.80% |
| Mar 31, 2023 | -33.12% |
| Dec 31, 2022 | -36.62% |
| Sep 30, 2022 | -6.25% |
| Jun 30, 2022 | -1.79% |
| Mar 31, 2022 | -60.38% |
| Dec 31, 2021 | -40.52% |
| Sep 30, 2021 | -66.49% |
| Jun 30, 2021 | -10.50% |